Clinical Trials Browser

Has results × Myeloproliferative Disorders × Imatinib Mesylate × Clear all

Bone Marrow Diseases, Hematologic Diseases, Immune System Diseases, Immunoproliferative Disorders, Leukemia, Leukemia, Myeloid, Lymphatic Diseases, Lymphoproliferative Disorders, Myeloproliferative Disorders, Neoplasms, Neoplasms by Histologic Type, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT00245128 2012-01-13

Imatinib Mesylate in Treating Patients With Myelofibrosis

Phase 2 Terminated

10 enrolled 6 charts

Myeloid

Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Primary Myelofibrosis

Clinical Trials

Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)

Imatinib Mesylate in Treating Patients With Myelofibrosis